DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nifenalol
Nifenalol
1-(4-Amino-Cyclohexyl)
Properties and Units in Clinical Pharmacology and Toxicology
Customs Tariff - Schedule
Ovid MEDLINE(R)
Novel Method of Administering Β-Blockers and Novel Dosage Forms Containing Same Anwar A
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Pharmaceutical Appendix to the Tariff Schedule 2
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
INFORMATION to USERS the Quality of This Reproduction Is
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs
Stembook 2018.Pdf
SUPPLEMENTARY MATERIAL 1: Search Strategy
2021 Equine Prohibited Substances List
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Index Vol. 16-23
Top View
United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
2020 Equine Prohibited Substances List
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
2019 Equine Prohibited Substances List
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
Pharmaabkommen A1 E
Drug-Resin Complexes Stabilized by Chelating Agents
Customs Tariff - Schedule Xxi - 1
LMEDLINE Database Summary Sheet
WO 2012/088441 Al 28 June 2012 (28.06.2012) P O P C T
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
2019 Banned Substances List.Pdf
Harmonized Tariff Schedule of the United States (2006) (Rev
Euregio Laboratory Services MCP Aimed at Horses – Pharmacologic Drug Library
United States Patent [191 [11] Patent Number: 4,468,391 Voith [45] Date of Patent: Aug
Adrenergic Blockers in Regard to Their Stereochemistry
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmacological Evaluation of Trimetoquinol Analogs As Affinity
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
FEI EPSL Banned Substances, 25 November 2019
Ep 1472225 B1
Identification and Characterization of Antidiabetic And
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
Wo 2011/017108 A2